Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537350 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
A NA study of Skin, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT05537350 is a NA study of Skin that has completed, run by LycoRed. The registered enrollment target is 66 participants, above the 54-participant average among 5 other Skin trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05537350, a NA study of Skin, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will be enrolled in this clinical study to assess the efficacy of an oral supplement to change the characteristics of facial skin after 4 and 12 weeks of use and obtain consumer perception of the test product through the use of questionnaires. Study evaluations will include a comprehensive metabolic panel, Cutometer measurements, Canfield's VISIA-CR images, VapoMeter Measurements, and Consumer perception questionnaires.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lumenato
Study Locations (1)
New Jersey
- Eurofins | CRL, Inc. - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05537350
The ClinicalTrials.gov registry entry for NCT05537350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54-participant average among 5 other Skin trials with a reported enrollment target (22% higher). The listed sponsor is LycoRed, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 1 intervention - of which Lumenato is the first listed.
NCT05537350 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05537350 about?
NCT05537350 is a clinical study titled "A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato". Subjects will be enrolled in this clinical study to assess the efficacy of an oral supplement to change the characteristics of facial skin after 4 and 12 weeks of use and obtain consumer perception of the test product through the use of questionnaires. Study evaluations will include a comprehensive...
What is the current status of trial NCT05537350?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2022-01-04. Estimated completion is 2022-08-31.
What conditions does trial NCT05537350 study?
This clinical trial studies the following conditions: Skin.
What interventions are being tested in trial NCT05537350?
The interventions under investigation include: Lumenato (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05537350?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537350 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
RECRUITING · NA
-
Lumenato Nutritional Supplement on Skin Appearance
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
Trial of Ixazomib for Kaposi Sarcoma
RECRUITING · Phase 2
-
In Vivo Cross-Modal Imaging of Skin
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.